To further evaluate this possible interpretation, we note that among these six individuals, four are carriers of the MSH6 mutation, for which the time of onset of CRC is known to be delayed by approximately nine years, compared to MLH1 and MSH2 mutation carriers [18]. This evidence concerns the gene MSH2 and colorectal carcinoma.